Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Sanquin neemt deel aan internationale alliantie ter ontwikkeling COVID-19-geneesmiddel
mei 2020 | Virale infecties